Depo Provera lawsuit settlements are gaining momentum in 2026 as thousands of women push claims against Pfizer. These lawsuits center on a frightening allegation: the popular birth control shot significantly increases the risk of meningioma brain tumors.
If you used Depo Provera and developed a meningioma, you may be owed substantial compensation. Estimated payouts range from $75,000 to over $500,000 depending on injury severity.
This article breaks down everything you need to know right now. You’ll find settlement projections, eligibility requirements, filing steps, deadlines, and the latest court updates for 2026.
One stat worth knowing: a major French study found that prolonged use of medroxyprogesterone acetate increased meningioma risk by up to five times. That research helped ignite this wave of litigation.
Depo Provera Lawsuit Settlements
Depo Provera lawsuit settlements refer to compensation agreements between plaintiffs and Pfizer over brain tumor injuries linked to the injectable birth control. As of 2026, no global settlement has been reached yet, but the litigation is positioned for potential resolution.
Thousands of lawsuits have been consolidated into multidistrict litigation. The cases allege that Pfizer and its subsidiary Pharmacia & Upjohn failed to warn patients about the connection between Depo Provera and meningioma tumors.
Settlement negotiations typically begin after bellwether trials establish how juries view the evidence. Those early test cases are expected to shape the terms of any mass settlement offer.
| Settlement Detail | Current Status (2026) |
|---|---|
| Global Settlement Reached | Not yet |
| Number of Filed Cases | Thousands and growing |
| MDL Consolidated | Yes |
| Bellwether Trials | Scheduled or in progress |
| Expected Settlement Window | Late 2026 to 2027 |
The strength of the scientific evidence linking Depo Provera to meningiomas gives plaintiffs real leverage in negotiations. Pfizer faces pressure from multiple directions, including regulatory scrutiny and ongoing case filings.
If bellwether verdicts favor plaintiffs, Pfizer will have strong financial incentive to settle. The alternative is facing thousands of individual jury trials, which would cost billions.
Depo Provera Lawsuit Payout
A Depo Provera lawsuit payout is the money a claimant receives after their case is resolved through settlement or trial verdict. Payouts will vary widely based on the severity of each person’s brain tumor diagnosis and treatment.
Legal analysts project three general payout tiers for these cases. Women who underwent brain surgery will likely receive the highest amounts. Those with tumors under active monitoring may receive lower but still meaningful compensation.
Think of it like car accident claims: a fender bender gets a smaller check than a totaled vehicle. The more serious the harm, the larger the payout.
| Injury Tier | Estimated Payout Range |
|---|---|
| Tier 1: Brain surgery required | $250,000 to $500,000+ |
| Tier 2: Tumor diagnosed, no surgery yet | $100,000 to $250,000 |
| Tier 3: Tumor monitoring or minor treatment | $75,000 to $150,000 |
| Wrongful death cases | $500,000 to $1,000,000+ |
These figures are projections based on similar pharmaceutical mass tort cases. Actual payouts depend on trial outcomes, settlement fund structures, and individual case strength.
Your payout will also reflect documented medical expenses, lost wages, and pain and suffering. Strong medical records make a real difference.
Depo Provera Lawsuit Settlement Amounts
Depo Provera lawsuit settlement amounts are the specific dollar figures claimants could receive once cases resolve. While no final amounts exist in 2026, past pharmaceutical mass torts provide useful benchmarks.
For comparison, the Zantac cancer litigation saw individual settlements ranging from $50,000 to over $300,000. The Essure birth control lawsuits settled in ranges of $10,000 to $50,000 per claim.
Depo Provera cases involve brain tumors, which are far more severe injuries. That severity pushes projected settlement amounts higher than most contraceptive product liability cases.
- Brain tumors require expensive treatment: surgery, radiation, long recovery
- Many plaintiffs suffered permanent neurological damage
- Some cases involve wrongful death
- Pfizer’s awareness of the risk strengthens plaintiff arguments
The total settlement fund, if Pfizer agrees to one, could reach into the billions. How that fund gets divided depends on the number of qualifying claims and the severity scoring system the court adopts.
Every dollar figure you see right now is an estimate. Real numbers come after bellwether trials or a global settlement agreement.
Key Takeaway: Depo Provera lawsuit payouts are projected between $75,000 and $500,000+ per claim, with brain surgery cases at the top and monitoring cases at the lower end.
Depo Provera Settlement Payout Per Person
The Depo Provera settlement payout per person will depend on a points-based system that scores each claimant’s injuries. This is how most pharmaceutical mass tort settlements distribute funds fairly.
Courts typically assign points based on several factors. The more points you accumulate, the higher your individual share of the settlement fund.
| Factor | Impact on Payout |
|---|---|
| Duration of Depo Provera use | Longer use = more points |
| Tumor size and location | Larger or more dangerous = more points |
| Surgery required (craniotomy) | Significantly increases payout |
| Permanent disability or impairment | Major points increase |
| Age at diagnosis | Younger patients may receive more |
| Lost income documentation | Adds to total compensation |
| Out-of-pocket medical costs | Directly reimbursable |
A woman who received Depo Provera injections for ten years and needed brain surgery would score far higher than someone who used it for two years and has a small, monitored tumor.
Keep every medical record, prescription history, and receipt. Documentation is what separates a strong claim from a weak one.
Attorney fees will typically take 33% to 40% of your settlement. Factor that into your expected net payout.
How Much Is the Depo Provera Lawsuit Worth
The Depo Provera lawsuit is worth an estimated $2 billion to $10 billion in total potential liability for Pfizer. That range reflects the number of women who used the drug and the severity of meningioma injuries.
Individual case values depend on your specific medical history. A case with documented brain surgery, lost wages, and ongoing treatment needs is worth far more than a case with minimal medical records.
Here’s what drives the value of each claim:
- Medical severity: Brain surgery cases are the most valuable
- Causation strength: How clearly your tumor links to Depo Provera use
- Documentation quality: Medical records, injection history, imaging scans
- Economic damages: Lost income, medical bills, future care costs
- Non-economic damages: Pain, suffering, reduced quality of life
Wrongful death cases carry the highest individual value. Families who lost a loved one to a meningioma after Depo Provera use could see settlements exceeding $1 million.
The litigation’s total worth also depends on how many women file claims. As public awareness grows in 2026, case numbers are expected to increase significantly.
Average Depo Provera Lawsuit Payout
The average Depo Provera lawsuit payout is projected at roughly $150,000 to $300,000 per settled claim. This estimate draws from comparable pharmaceutical brain injury lawsuits.
No one has received a payout yet in 2026 because the litigation is still in its pretrial phases. But averages from similar cases help paint the picture.
| Comparable Lawsuit | Average Payout |
|---|---|
| Zantac (cancer claims) | $50,000 to $300,000 |
| Talcum Powder (ovarian cancer) | $100,000 to $1,000,000 |
| Essure (birth control device) | $10,000 to $50,000 |
| Depo Provera (projected) | $150,000 to $300,000 |
The Depo Provera average will likely land between the Essure and talcum powder ranges. Brain tumors are more severe than many other pharmaceutical injuries, which pushes the average higher.
Keep in mind that “average” includes both high-value surgical cases and lower-value monitoring cases blended together. Your individual payout could be well above or below the average.
The first bellwether trial verdicts will give us much better data on realistic averages. Those trials are the real measuring stick.
Key Takeaway: The average Depo Provera payout is projected around $150,000 to $300,000, but individual amounts will vary dramatically based on injury severity and documentation.
Depo Provera Meningioma Lawsuit
The Depo Provera meningioma lawsuit alleges that Pfizer’s injectable contraceptive causes meningioma brain tumors. Meningiomas are tumors that form in the membranes surrounding the brain and spinal cord.
While most meningiomas are classified as benign, they are far from harmless. These tumors can cause seizures, vision loss, hearing problems, cognitive decline, and severe headaches. Surgery to remove them involves opening the skull, a procedure called craniotomy.
The scientific basis for these lawsuits is strong. A landmark 2024 study published in the BMJ found that women who used medroxyprogesterone acetate (the active ingredient in Depo Provera) for more than one year had a significantly elevated risk of intracranial meningioma.
Key scientific findings supporting the lawsuits:
- Meningioma cells contain progesterone receptors
- Depo Provera delivers high doses of synthetic progesterone
- Risk increases with duration of use
- French health authorities (ANSM) issued warnings based on their own studies
- The WHO acknowledged the potential link
Pfizer is accused of knowing about these risks for years and failing to update warning labels. That “failure to warn” claim is the legal backbone of every filed case.
Depo Provera Brain Tumor Lawsuit
The Depo Provera brain tumor lawsuit specifically targets the development of intracranial tumors in women who received the birth control injection. Brain tumors are the central injury driving this entire wave of litigation.
Not every brain tumor qualifies. The lawsuits focus on meningiomas, which grow from the meninges, the protective layers around the brain. Other types of brain tumors are not currently included in most claims.
Symptoms that often lead to diagnosis include:
- Persistent headaches that worsen over time
- Vision changes or loss
- Hearing difficulties
- Memory problems or confusion
- Seizures with no prior history
- Weakness in arms or legs
Many women didn’t connect their symptoms to Depo Provera at first. The tumors can grow slowly over years, making it hard to spot the link without medical investigation.
| Brain Tumor Detail | Lawsuit Relevance |
|---|---|
| Tumor type | Meningioma (intracranial) |
| Growth rate | Often slow-growing |
| Treatment | Surgery, radiation, or monitoring |
| Connection to Depo Provera | Progesterone receptor activation |
| Diagnosis timing | Often years after first injection |
If you’ve been diagnosed with any brain tumor after using Depo Provera, it’s worth having a medical professional review whether it’s a meningioma. That diagnosis is the gateway to a valid claim.
Who Qualifies for the Depo Provera Lawsuit
Women who received Depo Provera injections and were later diagnosed with a meningioma brain tumor are the primary group who qualifies. Both current and former users may be eligible.
Qualification isn’t automatic, though. You need to meet several criteria for your case to move forward.
Basic eligibility requirements:
- You received at least one Depo Provera injection
- You were diagnosed with an intracranial meningioma
- The diagnosis came after you started using Depo Provera
- You have medical records confirming both the injections and the tumor
Longer use strengthens your case. Women who received injections for one year or more have the strongest claims based on current scientific evidence.
| Eligibility Factor | Stronger Claim | Weaker Claim |
|---|---|---|
| Duration of use | 1+ years | Single injection |
| Tumor diagnosis | Confirmed meningioma | Undiagnosed symptoms |
| Medical records | Complete injection history | Partial or missing records |
| Treatment received | Surgery performed | No treatment yet |
| Timing | Tumor found during or after use | Tumor predated use |
Family members of women who died from meningiomas linked to Depo Provera may also qualify to file wrongful death claims.
You don’t need to have used Depo Provera recently. Women who received injections years or even decades ago can still file if they meet the criteria.
Key Takeaway: You qualify if you used Depo Provera and were diagnosed with a meningioma, with the strongest cases involving prolonged use and surgical treatment.
Depo Provera Lawsuit Eligibility
Depo Provera lawsuit eligibility is determined by three primary factors: proof of drug use, a confirmed meningioma diagnosis, and a plausible timeline connecting the two. All three must be present.
The first step is confirming your injection history. Pharmacy records, insurance claims, and doctor visit notes can all serve as proof. If your provider kept electronic health records, this is usually straightforward.
Next, you need a confirmed meningioma diagnosis. An MRI or CT scan showing the tumor is the standard medical evidence. Pathology reports from surgery provide even stronger documentation.
Finally, the timeline matters. Your tumor diagnosis should have occurred during or after your Depo Provera use. If you were diagnosed with a meningioma before your first injection, your case would be much harder to prove.
Factors that strengthen eligibility:
- Multiple years of consecutive injections
- No family history of meningiomas
- No other known risk factors (like radiation exposure)
- Documented neurological symptoms
- Surgical intervention required
Factors that could complicate eligibility:
- Very short duration of use (one or two injections only)
- Pre-existing brain tumor before Depo Provera use
- Incomplete or missing medical records
- Tumor type other than meningioma
An experienced mass tort attorney can review your records and assess your eligibility within days. Most offer free case evaluations.
Depo Provera Lawsuit Update 2026
The Depo Provera lawsuit update for 2026 shows significant litigation progress. Cases have been consolidated, bellwether trials are being organized, and new plaintiffs continue to file at a rapid pace.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated these cases into an MDL for more efficient handling. This means all federal Depo Provera meningioma lawsuits are being managed by a single judge.
Here’s where things stand in 2026:
| Milestone | Status |
|---|---|
| MDL Consolidation | Complete |
| Discovery Phase | Ongoing |
| Bellwether Trial Selection | In progress |
| First Bellwether Trial | Expected 2026 |
| Global Settlement Talks | Preliminary |
| New Case Filings | Actively accepted |
The discovery phase is where attorneys on both sides exchange documents, depose witnesses, and gather evidence. Pfizer has been required to produce internal documents about what it knew regarding meningioma risks and when it knew it.
Bellwether trials are the next critical milestone. These test cases go to trial first and help both sides gauge how juries will react. If plaintiffs win big verdicts, Pfizer will face enormous pressure to settle.
Public awareness campaigns and media coverage have driven a surge in new filings throughout early 2026. The total number of cases is expected to keep climbing.
Depo Provera MDL Update
The Depo Provera MDL (Multidistrict Litigation) update shows that the consolidated federal cases are progressing through pretrial proceedings. MDL is the legal mechanism that groups similar federal lawsuits together for efficiency.
In an MDL, one judge oversees all pretrial matters: discovery, motions, and bellwether trial scheduling. This prevents contradictory rulings across different courts and speeds up the overall process.
Think of MDL like a traffic roundabout. All the cars (cases) enter from different directions but move through the same central process before heading to their final destination.
Key MDL facts for 2026:
- All federal Depo Provera meningioma cases are in the MDL
- State-level lawsuits may proceed separately
- Discovery is producing internal Pfizer documents
- Expert witness reports on causation are being filed
- Daubert hearings (challenges to scientific evidence) are expected
The MDL judge will select a small number of bellwether cases, usually four to six, to go to trial first. These cases represent different types of injuries and usage patterns.
Outcomes from bellwether trials typically determine whether a global settlement follows. Strong plaintiff verdicts often lead to settlement negotiations within months.
If you haven’t filed yet, the MDL is still accepting new cases. Filing now means your claim gets included in the consolidated proceedings.
Key Takeaway: The Depo Provera MDL is in active pretrial proceedings in 2026, with bellwether trials expected to shape the path toward a potential global settlement.
Depo Provera Lawsuit Timeline 2026
The Depo Provera lawsuit timeline for 2026 maps out the expected legal milestones from pretrial proceedings through potential settlement. Here’s a projected timeline based on the current pace of litigation.
| Phase | Estimated Timeframe |
|---|---|
| MDL Discovery Completion | Mid 2026 |
| Bellwether Case Selection Finalized | Early to mid 2026 |
| First Bellwether Trial | Late 2026 |
| Bellwether Verdict(s) | Late 2026 to early 2027 |
| Settlement Negotiations (if triggered) | 2027 |
| Settlement Payments Begin | 2027 to 2028 |
These timelines can shift. Court delays, continuances, and legal motions from Pfizer could push things back. But the current trajectory suggests meaningful progress by the end of 2026.
The first bellwether trial is the single biggest event on the horizon. Everything else flows from how that trial goes.
If the plaintiff wins a large verdict, settlement talks will likely accelerate. If Pfizer wins, they may dig in and fight more cases, which would extend the timeline.
For people waiting on payouts, patience is required. Even after a settlement agreement is reached, the claims review process and payment distribution can take six to twelve months.
Filing sooner rather than later is smart. Early filers are better positioned in settlement structures and avoid statute of limitations risks.
Depo Provera Side Effects Lawsuit
The Depo Provera side effects lawsuit focuses primarily on meningioma brain tumors, but the drug has a long history of side effect concerns. The lawsuits allege that Pfizer failed to adequately warn users about the most serious risks.
Depo Provera (medroxyprogesterone acetate) has been on the market since 1992. Over the years, it has carried FDA warnings about bone density loss. But the meningioma risk was not prominently disclosed to patients or prescribing doctors.
Side effects central to the lawsuits:
- Intracranial meningioma (brain tumor)
- Seizures related to tumor growth
- Vision and hearing loss
- Cognitive impairment
- Need for brain surgery (craniotomy)
Other known Depo Provera side effects (not part of current lawsuits):
- Bone density reduction
- Weight gain
- Irregular bleeding
- Mood changes
- Delayed return of fertility
The legal argument is focused: Pfizer knew or should have known about the meningioma risk and didn’t tell anyone. Internal documents being produced during discovery may reveal exactly what Pfizer knew and when.
The FDA has not yet added a specific meningioma warning to Depo Provera’s label in the United States, although French and European health authorities have taken action. That regulatory gap is part of the plaintiffs’ argument.
How to File a Depo Provera Lawsuit
To file a Depo Provera lawsuit, you need to contact a mass tort attorney, provide your medical records, and have your case evaluated for inclusion in the MDL or state-level proceedings. The process is straightforward.
Step-by-step filing process:
- Gather your records: Collect injection history, pharmacy records, MRI or CT scan results, surgical reports, and any neurological treatment documentation
- Contact an attorney: Reach out to a law firm that handles pharmaceutical mass tort cases; most offer free consultations
- Case evaluation: The attorney reviews your records to confirm eligibility
- Retainer agreement: If you qualify, you sign a contingency fee agreement (you pay nothing upfront)
- Filing: Your attorney files the lawsuit in the appropriate court (federal MDL or state court)
- Pretrial proceedings: Your case enters the discovery and litigation process
Most attorneys work on a contingency fee basis. That means they only get paid if you win or settle. Standard fees range from 33% to 40% of your recovery.
You don’t need to appear in court during the pretrial phase. Your attorney handles all filings, motions, and negotiations on your behalf.
The entire initial process, from first contact to filed complaint, typically takes two to four weeks.
Key Takeaway: Filing a Depo Provera lawsuit requires medical records showing both drug use and a meningioma diagnosis, and most attorneys handle these cases on a contingency fee basis with no upfront cost.
Depo Provera Lawsuit Deadline
The Depo Provera lawsuit deadline depends on your state’s statute of limitations for personal injury or product liability claims. Missing the deadline means losing your right to sue permanently.
Statutes of limitations vary by state. Most states give you two to three years from the date you discovered (or should have discovered) your injury. This is called the “discovery rule.”
| State Example | Statute of Limitations |
|---|---|
| California | 2 years from discovery |
| Texas | 2 years from discovery |
| New York | 3 years from discovery |
| Florida | 2 years from discovery (recently changed from 4) |
| Illinois | 2 years from discovery |
| Pennsylvania | 2 years from discovery |
The discovery rule is important here. Many women were diagnosed with meningiomas but didn’t learn about the Depo Provera connection until recent media coverage. Your clock may start from when you learned the drug could have caused your tumor, not from the date of diagnosis.
However, don’t assume you have unlimited time. Courts interpret discovery rules differently. Some judges take a strict view of when you “should have known.”
The safest approach: File as soon as possible. Even if you think your deadline is far away, contacting an attorney now protects your rights.
If your state’s deadline has arguably passed, an attorney can evaluate whether any exceptions or tolling provisions apply to your situation.
Depo Provera Lawsuit Evidence
Depo Provera lawsuit evidence includes medical records, scientific studies, internal company documents, and expert witness testimony. Strong evidence is what separates cases that settle for top dollar from ones that settle for less.
Types of evidence used in these cases:
- Medical records: MRI/CT scans showing meningioma, surgical reports, pathology results
- Injection history: Pharmacy records, insurance billing codes, doctor visit notes
- Scientific studies: The BMJ study, French ANSM research, and peer-reviewed articles linking medroxyprogesterone acetate to meningiomas
- Internal Pfizer documents: Produced during discovery, showing what the company knew about risks
- Expert witnesses: Neurologists, oncologists, and epidemiologists who can testify about causation
The strongest plaintiffs have a clear, unbroken chain of evidence. You can trace from the first injection to the tumor diagnosis to the treatment received.
| Evidence Type | Why It Matters |
|---|---|
| Injection records | Proves you used the drug |
| MRI/CT scans | Confirms meningioma diagnosis |
| Surgical reports | Shows severity of injury |
| Employment records | Documents lost wages |
| Out-of-pocket receipts | Proves economic damages |
| Scientific literature | Establishes causation link |
If you’re worried about gaps in your records, don’t panic. Attorneys have investigators and medical records specialists who can help reconstruct your history from insurance databases and pharmacy systems.
Start gathering what you can now. Every piece of documentation strengthens your position.
Is There a Class Action for Depo Provera
There is no Depo Provera class action lawsuit. The cases are handled as individual lawsuits consolidated in a multidistrict litigation (MDL), which is a different legal structure than a class action.
People often confuse class actions with MDLs because both involve many plaintiffs suing the same defendant. But the differences matter for your payout.
Class Action vs. MDL:
| Feature | Class Action | MDL |
|---|---|---|
| Individual claims | No, one claim for the group | Yes, each person has their own case |
| Payout structure | Equal or near-equal split | Based on individual damages |
| Control over your case | Minimal | More control |
| Settlement amounts | Usually lower per person | Usually higher per person |
| Common in | Consumer fraud, overcharges | Product liability, pharmaceuticals |
In a class action, everyone gets the same small check. In an MDL, your payout reflects your specific injuries, medical costs, and suffering. That’s much better for people with serious injuries like brain tumors.
Each plaintiff in the Depo Provera MDL maintains their own individual claim. Your case is evaluated on its own merits, even though pretrial proceedings are handled together for efficiency.
This structure means you could receive significantly more money than you would in a class action. It also means your medical records and personal history matter more.
Key Takeaway: Depo Provera cases are handled through an MDL, not a class action, which means each person’s payout is based on their individual injuries rather than a flat per-person amount.
Frequently Asked Questions
How much money will I get from a Depo Provera lawsuit settlement?
Most claimants can expect between $75,000 and $500,000 depending on injury severity.
Cases involving brain surgery receive the highest payouts, while monitoring-only cases receive less.
No payments have been distributed yet in 2026 because the litigation is still in pretrial phases.
Who qualifies for the Depo Provera meningioma lawsuit in 2026?
Women who received Depo Provera injections and were diagnosed with an intracranial meningioma qualify.
You need medical records showing both the injection history and the tumor diagnosis.
Longer duration of use and more severe injuries strengthen your eligibility.
What is the deadline to file a Depo Provera lawsuit?
The deadline varies by state but typically falls within two to three years from when you discovered the connection between Depo Provera and your tumor.
Some states apply a discovery rule that may extend your window.
Contact an attorney now to confirm your specific deadline.
Has Pfizer settled any Depo Provera brain tumor cases yet?
Pfizer has not reached a global settlement or settled individual Depo Provera meningioma cases as of 2026.
The litigation is still in the discovery and bellwether trial preparation stages.
Settlement negotiations are expected to begin after the first bellwether trial verdicts.
How long will it take to get a Depo Provera lawsuit payout?
Payouts are not expected until late 2027 or 2028 at the earliest.
The timeline depends on bellwether trial outcomes and whether Pfizer agrees to a settlement.
After a settlement is reached, the claims review and payment process typically takes six to twelve months.
What to Do Right Now
The Depo Provera lawsuit is one of the most significant pharmaceutical cases moving through the courts in 2026. If you used this drug and were diagnosed with a meningioma, your window to act is open right now.
Gather your medical records, including injection history and brain imaging results. Reach out to a qualified mass tort attorney for a free case evaluation.
Don’t wait for a settlement announcement to start your claim. Filing early positions you better and protects you against statute of limitations risks. The time to act is now.
